ATE235249T1 - Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen - Google Patents

Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen

Info

Publication number
ATE235249T1
ATE235249T1 AT97948274T AT97948274T ATE235249T1 AT E235249 T1 ATE235249 T1 AT E235249T1 AT 97948274 T AT97948274 T AT 97948274T AT 97948274 T AT97948274 T AT 97948274T AT E235249 T1 ATE235249 T1 AT E235249T1
Authority
AT
Austria
Prior art keywords
morphogenic
restoration
peptides
tissue
cells caused
Prior art date
Application number
AT97948274T
Other languages
English (en)
Inventor
Kuber Sampath
David C Rueger
Charles M Cohen
Marc F Charette
Donald F Jin
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25021057&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE235249(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Curis Inc filed Critical Curis Inc
Application granted granted Critical
Publication of ATE235249T1 publication Critical patent/ATE235249T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
AT97948274T 1996-11-15 1997-11-14 Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen ATE235249T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75122796A 1996-11-15 1996-11-15
PCT/US1997/020743 WO1998020890A1 (en) 1996-11-15 1997-11-14 Morphogen peptide-induced regeneration of sense perceptory tissues

Publications (1)

Publication Number Publication Date
ATE235249T1 true ATE235249T1 (de) 2003-04-15

Family

ID=25021057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97948274T ATE235249T1 (de) 1996-11-15 1997-11-14 Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen

Country Status (10)

Country Link
EP (1) EP0956038B1 (de)
JP (1) JP2001504469A (de)
AT (1) ATE235249T1 (de)
AU (2) AU5244998A (de)
CA (1) CA2271696A1 (de)
DE (1) DE69720275T2 (de)
DK (1) DK0956038T3 (de)
ES (1) ES2194225T3 (de)
PT (1) PT956038E (de)
WO (2) WO1998020889A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69723429T3 (de) * 1996-03-22 2007-09-20 Curis, Inc., Cambridge Verfahren zur verbesserten funktionellen Erholung der motorischen Koordination, der Sprache oder Sinneswahrnehmung nach Trauma oder Ischämie des ZNS
PL373863A1 (en) 2001-10-31 2005-09-19 Alcon, Inc. Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
CN109182250A (zh) * 2018-09-30 2019-01-11 山东省立医院 一种小鼠耳蜗毛细胞培养方法
CN111175789B (zh) * 2020-01-16 2022-03-04 中国民用航空总局第二研究所 地基增强系统的电离层异常监测方法、装置以及系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270748A (en) * 1992-01-30 1993-12-14 Mak Technologies, Inc. High-speed eye tracking device and method
EP0653942B2 (de) * 1992-07-31 2007-03-07 Curis, Inc. Morphogen induzierte nerven wiederherstellung und wiedergutmachung.
AU709991B2 (en) * 1995-08-14 1999-09-09 Creative Biomolecules, Inc. Binding of osteogenic protein-1 (OP-1) and analogs thereof to the cell surface receptor ALK-1 and analogs thereof
EP0866716A4 (de) * 1995-11-13 2002-05-02 Cambridge Neuroscience Inc Verfahren zur behandlung von störungen des nichtvisuellen sensorischen epithels
US5929041A (en) * 1996-02-23 1999-07-27 Amgen Inc. Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor(GDNF) protein product
DE69723429T3 (de) * 1996-03-22 2007-09-20 Curis, Inc., Cambridge Verfahren zur verbesserten funktionellen Erholung der motorischen Koordination, der Sprache oder Sinneswahrnehmung nach Trauma oder Ischämie des ZNS

Also Published As

Publication number Publication date
WO1998020890A1 (en) 1998-05-22
EP0956038A1 (de) 1999-11-17
WO1998020889A1 (en) 1998-05-22
CA2271696A1 (en) 1998-05-22
AU5436798A (en) 1998-06-03
ES2194225T3 (es) 2003-11-16
DE69720275T2 (de) 2003-12-11
DK0956038T3 (da) 2003-07-21
JP2001504469A (ja) 2001-04-03
DE69720275D1 (de) 2003-04-30
PT956038E (pt) 2003-08-29
EP0956038B1 (de) 2003-03-26
AU5244998A (en) 1998-06-03

Similar Documents

Publication Publication Date Title
BG101132A (en) Pyridoanilated thienyl and furanyl oxazolidinons
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
UA42747C2 (uk) Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
DE69533991D1 (de) Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
ATE396205T1 (de) Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe
DE69738613D1 (de) Prävention und behandlung von skeletterkrankungen mit ep2 subtyp selektiven prostaglandin e2 agonisten
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
ZA951974B (en) Bradykinin antagonist peptides incorporating N-subsituted glycines
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
DE60008143D1 (de) Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
PL316656A1 (en) Free halophantrin base for use in treating marsh-fever and compositions containing same
ATE235249T1 (de) Die von morphogenen peptiden hervorgerufene wiederherstellung von gewebe aus sinneszellen
PT888114E (pt) Utilizacao de (+)-alfa-(2,3-dimetoxifenil)-1-¬2-(4-fluorofenil)etil|-4-piperidinometanol no tratamento de doencas depressivas e doencas bipolares
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
TR200200278T2 (tr) Kalsilitik bileşimler
TR199901385T2 (xx) Piperidin t�revleri.
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties